Population Health (187)

Brian Spisak, a Harvard research associate, discusses how a "leadership-first, tech-last" approach can raise satisfaction and address burnout among healthcare staff.

The U.S. health system is not a system but a convoluted array of institutions, says Hannes Klöpper, HelloBetter cofounder and CEO. Using digital therapeutics is one way to lower barriers to care and improve cost efficiency and access.

Dr. Alexander Ryu, vice chair of AI and innovation at Mayo Clinic, discusses how his team builds and uses AI and ensures a lack of bias in its models by involving clinicians and when the team decides to partner with established AI companies.

Pravin Pant, VP of advanced analytics, and Michael Gould, associate VP of interoperability strategy, both at ZeOmega, talk about how the company uses AI to identify vulnerable patient populations and suggest ways to improve their health outcomes.

Jesus Diaz, director of nursing informatics at Memorial Healthcare System, talks about how the health system has increased patient engagement and encouraged preventative care through a mobile app linked to its EHR.

Since EHR systems are built around the traditional fee-for-service care model, Dr. Harm Scherpbier, HealthShare Exchange CMIO, says new technology is being developed to work alongside them to enable data sharing for value-based care.

Aaron Gani, founder and CEO of RealizedCare, discusses how business models have changed in digital therapeutics as technology evolves and how pharma can leverage DTx modalities to collect data for R&D and thoroughly analyze patients.

Dr. Dennis Truong, regional telemedicine/mobility director at Kaiser Permanente, discusses the rise of digital therapeutics in healthcare and how it has helped the health system improve the care experience for patients and providers.

Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses what a digital therapeutic is exactly, why the organization held its recent summit in D.C. and how the company works with Congress on legislation around reimbursement.

Scott Stuewe, president and CEO of DirectTrust, and Andy Molnar, CEO of the Digital Therapeutics Alliance, highlight the partners' efforts to move digital therapeutics forward by ensuring validation and accreditation in healthcare.

In discussing the Quadruple Aim, Dr. Alan Forster, director of Innovation, Transformation and Clinical Performance at McGill University Health Centre, says data gives measurable insights on care gaps and allows the evaluation of goals.

Oscar Alleyne, MITRE's managing director of the public health division, discusses the value of public and private partnerships to advance public health innovations and what its FFRDCs do to help organizations plan for the next pandemic.